Introducing the BioXp® 9600 system

Telesis Bio recently announced the commercial release of the BioXp® 9600 system – a fully automated, high-throughput benchtop platform for synthetic biology workflows designed to empower scientists to accelerate discovery of new vaccines and biologics. The BioXp 9600 system expands on the capability of the award-winning BioXp platform, offering greater throughput, performance, and versatility in workflow capability. The state-of-the art automation design combined with proprietary Gibson Assembly and error correction chemistry enables turnkey synthesis, assembly and cloning of up to 96 unique sequences in a single overnight run. Learn more: